Srijith Rangan

Author Archive

  • Sep 9, 2026
    We should let the FDA focus on determining whether a drug is safe enough to use, and let patients, physicians, and insurers decide whether it is worth paying for.
  • Sep 8, 2026
    We should let the FDA focus on determining whether a drug is safe enough to use, and let patients, physicians, and insurers decide whether it is worth paying for.